Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay
Annelies Cannaert, Jolien Storme, Florian Franz, et al.
Analytical Chemistry (2016) Vol. 88, Iss. 23, pp. 11476-11485
Open Access | Times Cited: 211

Showing 1-25 of 211 citing articles:

Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
Aviv Weinstein, Paola Rosca, Liana Fattore, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 181
NanoBRET: The Bright Future of Proximity-Based Assays
Natasha C. Dale, Elizabeth K. M. Johnstone, Carl W. White, et al.
Frontiers in Bioengineering and Biotechnology (2019) Vol. 7
Open Access | Times Cited: 153
The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review
Vera L. Alves, João Gonçalves, Joselin Aguiar, et al.
Critical Reviews in Toxicology (2020) Vol. 50, Iss. 5, pp. 359-382
Closed Access | Times Cited: 153
Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review
Daniel Pasin, Adam Cawley, Sergei Bidny, et al.
Analytical and Bioanalytical Chemistry (2017) Vol. 409, Iss. 25, pp. 5821-5836
Open Access | Times Cited: 121
New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites
Xingxing Diao, Marilyn A. Huestis
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 118
Synthetic Pot: Not Your Grandfather’s Marijuana
Benjamin M. Ford, Sherrica Tai, William E. Fantegrossi, et al.
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 3, pp. 257-276
Open Access | Times Cited: 92
Activity-Based Detection of Consumption of Synthetic Cannabinoids in Authentic Urine Samples Using a Stable Cannabinoid Reporter System
Annelies Cannaert, Florian Franz, Volker Auwärter, et al.
Analytical Chemistry (2017) Vol. 89, Iss. 17, pp. 9527-9536
Open Access | Times Cited: 91
Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices
Silvia Graziano, Luca Anzillotti, Giulio Mannocchi, et al.
Journal of Pharmaceutical and Biomedical Analysis (2018) Vol. 163, pp. 170-179
Closed Access | Times Cited: 84
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Elise Wouters, Jolien Walraed, Samuel D. Banister, et al.
Biochemical Pharmacology (2019) Vol. 169, pp. 113623-113623
Closed Access | Times Cited: 79
Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA
Annelies Cannaert, Eric Sparkes, Edward Pike, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 24, pp. 4434-4446
Closed Access | Times Cited: 79
Molecularly imprinted polymer based quartz crystal microbalance sensor system for sensitive and label-free detection of synthetic cannabinoids in urine
Dīlek Battal, Semra Akgönüllü, M. Serkan Yalçın, et al.
Biosensors and Bioelectronics (2018) Vol. 111, pp. 10-17
Closed Access | Times Cited: 79
Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
Laura Hondebrink, Anne Zwartsen, Remco H.S. Westerink
Pharmacology & Therapeutics (2017) Vol. 182, pp. 193-224
Open Access | Times Cited: 76
Application of an activity‐based receptor bioassay to investigate the in vitro activity of selected indole‐ and indazole‐3‐carboxamide‐based synthetic cannabinoids at CB1 and CB2 receptors
Carolina Noble, Annelies Cannaert, Kristían Línnet, et al.
Drug Testing and Analysis (2018) Vol. 11, Iss. 3, pp. 501-511
Closed Access | Times Cited: 71
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes
Yurii Saroz, Dan T. Kho, Michelle Glass, et al.
ACS Pharmacology & Translational Science (2019) Vol. 2, Iss. 6, pp. 414-428
Open Access | Times Cited: 67
Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples
Lysbeth H. Antonides, Annelies Cannaert, Caitlyn Norman, et al.
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 63
Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling
Kenneth B. Walsh, Haley K. Andersen
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6115-6115
Open Access | Times Cited: 62
The Cambridge Handbook of Substance and Behavioral Addictions
Steve Sussman, Steve Sussman, Wilson M. Compton, et al.
Cambridge University Press eBooks (2020)
Open Access | Times Cited: 62
Rapid and sensitive detection of synthetic cannabinoids JWH-018, JWH-073 and their metabolites using molecularly imprinted polymer-coated QCM nanosensor in artificial saliva
Semra Akgönüllü, Dīlek Battal, M. Serkan Yalçın, et al.
Microchemical Journal (2019) Vol. 153, pp. 104454-104454
Closed Access | Times Cited: 58
Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA
David B. Finlay, Jamie J. Manning, Mikkel Søes Ibsen, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 10, pp. 4350-4360
Open Access | Times Cited: 57
Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds
Elise Wouters, Jolien Walraed, Michael J. Robertson, et al.
ACS Pharmacology & Translational Science (2019) Vol. 3, Iss. 2, pp. 285-295
Open Access | Times Cited: 56
The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent‐4en and but‐3en analogues including MDMB‐4en‐PINACA
Alex J. Krotulski, Annelies Cannaert, Christophe P. Stove, et al.
Drug Testing and Analysis (2020) Vol. 13, Iss. 2, pp. 427-438
Closed Access | Times Cited: 53
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 9, pp. 1565-1575
Open Access | Times Cited: 30
Development of a micro-solid-phase extraction molecularly imprinted polymer technique for synthetic cannabinoids assessment in urine followed by liquid chromatography–tandem mass spectrometry
Juan Sánchez‐González, Sara Odoardi, Ana María Bermejo, et al.
Journal of Chromatography A (2018) Vol. 1550, pp. 8-20
Open Access | Times Cited: 56
Cannabinoid Markers in Biological Fluids and Tissues: Revealing Intake
Marilyn A. Huestis, Michael L. Smith
Trends in Molecular Medicine (2018) Vol. 24, Iss. 2, pp. 156-172
Closed Access | Times Cited: 54
Immunoassay screening in urine for synthetic cannabinoids – an evaluation of the diagnostic efficiency
Florian Franz, Verena Angerer, Hanna Jechle, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2017) Vol. 55, Iss. 9
Closed Access | Times Cited: 52
Page 1 - Next Page

Scroll to top